Member access

4-Traders Homepage  >  Shares  >  Euronext Alternext  >  MEDIAN TECHNO    ALMDT   FR0011049824


SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

MEDIANTECHNOLOGIES : MEDIAN Technologies Names Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America

04/04/2012 | 01:35am US/Eastern

Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the relationship between MEDIAN and Quintiles

Regulatory News:

MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America. Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles.

Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years' experience in medical imaging with an emphasis in business development, strategic planning, and team management. Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET. He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies.

"I'm very excited to join MEDIAN at this time in their development," said Ciaran Cooper. "MEDIAN's LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials. I look forward to carrying our message to market."

"We're thrilled to welcome Ciaran to our team," said Jerome Windsor, VP Business Development at MEDIAN Technologies. "Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company."

About MEDIAN Technologies: MEDIAN Technologies provides advanced imaging solutions for diagnosing and monitoring cancer patients in clinical trials and in routine clinical practice. MEDIAN collaborates with institutes at the cutting edge of medical imaging, including the French National Institute for Computer Science and Control (INRIA), the University of Chicago, and the Swiss Federal Institute of Technology in Lausanne, Switzerland (EPFL). MEDIAN is present in the market through direct and indirect sales of its LMS solutions and through alliances with specialist cancer centers in Europe and the USA. MEDIAN has a strategic partnership with Quintiles, to offer integrated imaging services for clinical trials to customers worldwide.

Based in Sophia Antipolis, France, MEDIAN was founded in 2002 by Fredrik Brag (Current CEO), Gérard Milhiet, and Arnaud Butzbach. The company has a staff of 40, over half of whom work in R&D, and has a US-based subsidiary.

For more information on MEDIAN, please visit:

MEDIAN Technologies
Fredrik Brag, CEO
+33 4 92 90 65 82
Press - ALIZE RP
Caroline Carmagnol
+ 33 6 64 18 99 59 // + 33 1 42 68 86 43
Anne-Sophie Cosquéric
+ 33 1 42 68 86 41

© Business Wire 2012
Recommend :
React to this article
Latest news on MEDIAN TECHNO
06/19 MEDIAN TECHNO : ogies : is Laureate of FACCNE’s 13th Annual Business Award..
05/28 MEDIAN TECHNO : ogies : To Participate in the 2014 ASCO Annual Conference
04/08 MEDIAN TECHNO : ogies : Announces €422K Phase II Project Award
03/22 MEDIAN TECHNO : ogies Enters into EUR700K Pact with a Top 5 Pharmaceutical Compa..
03/17 MEDIAN TECHNO : ogies : Signs a Sales Contract with the University Hospital of P..
03/16 MEDIAN TECHNO : ogies Enters into EUR700K Agreement with a Top 5 Pharmaceutical ..
03/13 MEDIAN TECHNO : ogies Signs a €700K Contract with a Top Five Pharmaceutical Comp..
03/12 MEDIAN TECHNO : MEDIAN Technologies Signs a ?700K Contract with a Top Five Pharm..
03/05 MEDIAN TECHNO : MEDIAN Technologies to Present Results of Three Studies at the 2..
01/29 MEDIAN TECHNO : MEDIAN Technologies Announces ?639K Phase III Project Award
Duration : Period :
MEDIAN TECHNO Technical Analysis Chart | ALMDT | FR0011049824 | 4-Traders
Income Statement Evolution
MEDIAN TECHNO : Income Statement Evolution
More Financials
Dynamic quotes